Factor Bioscience
Cambridge, US · Delaware LLC
Find your way into Factor Bioscience
581 people in our graph share verified history with the Factor Bioscience team — schools, employers, funds. One of them is your warm intro.
Factor Bioscience develops mRNA, gene-editing, and cell-reprogramming technologies for cell engineering, including tools to repair disease-causing mutations and engineer immune cells to fight cancer. It works with strategic pharmaceutical and biotech partners across product development stages, from target identification through cell line development and manufacturing in its cleanrooms.
Founders & leadership

Reported raises · per SEC filings
Form D private placements$1M disclosed across 1 round · 2025
▶$1MraisedSep 2025 · 1 investors · BiotechnologyRule 506(b)
- Matthew AngelExecutive Officer, Director
- Christopher RohdeDirector
- Offering amount
- $5M
- Amount sold
- $1M
- First sale
- Sep 2025
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlapCompanies competing with Factor Bioscience for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Factor Bioscience do?
- Factor Bioscience develops mRNA, gene-editing, and cell-reprogramming technologies for cell engineering, including tools to repair disease-causing mutations and engineer immune cells to fight cancer. It works with strategic pharmaceutical and biotech partners across product development stages, from target identification through cell line development and manufacturing in its cleanrooms.
- Who founded Factor Bioscience?
- Factor Bioscience was founded by Christopher Rohde, Matt Angel.
- How much funding has Factor Bioscience raised?
- Factor Bioscience has disclosed $1M raised across 1 round.
- Where is Factor Bioscience headquartered?
- Factor Bioscience is headquartered in Cambridge, US.





